FDA Plans Ultra-Fast Review of Three Psychedelics for Depression, PTSD

FDA Plans Ultra-Fast Review of Three Psychedelics for Depression, PTSD

Summary

Recent moves on psychedelics reflect growing support for the substances among Trump's supporters

Description

Recent moves on psychedelics reflect growing support for the substances among Trump's supporters

Original reporting

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Open original source

Related coverage